Register for our free email digests:
Policy and Regulation
Regulation Explore this Topic
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Aspen Will Pay UK's NHS £8m In Landmark Deal Following Competition Probe
Aspen has agreed to pay the National Health Service £8m following an investigation by the Competition and Markets Authority.
Dr Reddy's Is Knocked Back On US NuvaRing And Copaxone Rivals
Dr Reddy’s has received a further CRL from the US Food and Drug Administration over its application for a generic rival to Merck Sharp & Dohme’s NuvaRing contraceptive, along with a CRL for its version of Teva’s Copaxone.
Pfenex And Alvogen May Face Delay In Teriparatide Equivalence Rating
Pfenex remains hopeful of receiving US approval for its teriparatide hybrid rival to Eli Lilly’s Forteo in October this year. But commercial partner Alvogen may have to wait for a therapeutic equivalence rating to the osteoporosis original.
Pricing Strategies; Reimbursement Explore this Topic
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Generics Players Dominating New OTC Launches In Germany
Industry Pact Aligns Canadian Prices To International Levels
An agreement between industry and authorities in effect from April last year is already having a major effect in ensuring Canadian generics prices are similar to those in other developed markets, an official report shows.
Teligent Prepares For Injectables Filings With Strengthened Team
As it prepares to start injectables filings from its facility in Buena, New Jersey, Teligent is putting in place its senior operational and quality functions.
Intellectual Property Explore this Topic
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Generics Players Dominating New OTC Launches In Germany
Industry Pact Aligns Canadian Prices To International Levels
An agreement between industry and authorities in effect from April last year is already having a major effect in ensuring Canadian generics prices are similar to those in other developed markets, an official report shows.
Teligent Prepares For Injectables Filings With Strengthened Team
As it prepares to start injectables filings from its facility in Buena, New Jersey, Teligent is putting in place its senior operational and quality functions.
Market Intelligence Explore this Topic
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Generics Players Dominating New OTC Launches In Germany
Industry Pact Aligns Canadian Prices To International Levels
An agreement between industry and authorities in effect from April last year is already having a major effect in ensuring Canadian generics prices are similar to those in other developed markets, an official report shows.
Teligent Prepares For Injectables Filings With Strengthened Team
As it prepares to start injectables filings from its facility in Buena, New Jersey, Teligent is putting in place its senior operational and quality functions.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.